ENLON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enlon, and what generic alternatives are available?
Enlon is a drug marketed by Mylan Institutional and Mylan and is included in three NDAs.
The generic ingredient in ENLON is atropine sulfate; edrophonium chloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENLON?
- What are the global sales for ENLON?
- What is Average Wholesale Price for ENLON?
Summary for ENLON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ENLON at DailyMed |
![ENLON drug patent expirations Drug patent expirations by year for ENLON](/p/graph/s/t/ENLON-patent-expirations.png)
US Patents and Regulatory Information for ENLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Institutional | ENLON | edrophonium chloride | INJECTABLE;INJECTION | 088873-001 | Aug 6, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Institutional | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |